%D8%B9%D8%AF%D9%88%D9%89_%D8%A7%D9%84%D9%81%D9%8A%D8%B1%D9%88%D8%B3_%D8%A7%D9%84%D8%BA%D8%AF%D9%8A%D0%90%D0%B4%D1%8D%D0%BD%D0%B0%D0%B2%D1%96%D1%80%D1%83%D1%81%D0%BD%D1%8B%D1%8F_%D1%85%D0%B2%D0%B0%D1%80%D0%BE%D0%B1%D1%8BHumane_AdenovirenAdenovirus_infectionInfecci%C3%B3n_por_adenovirusAdenoviirusinfektsioon%E5%92%BD%E9%A0%AD%E7%B5%90%E8%86%9C%E7%86%B1%E1%83%90%E1%83%93%E1%83%94%E1%83%9C%E1%83%9D%E1%83%95%E1%83%98%E1%83%A0%E1%83%A3%E1%83%A1%E1%83%A3%E1%83%9A%E1%83%98_%E1%83%98%E1%83%9C%E1%83%A4%E1%83%94%E1%83%A5%E1%83%AA%E1%83%98%E1%83%90%D0%90%D0%B4%D0%B5%D0%BD%D0%BE%D0%B2%D0%B8%D1%80%D1%83%D1%81%D1%82%D1%8B_%D0%B8%D0%BD%D1%84%D0%B5%D0%BA%D1%86%D0%B8%D1%8F%D0%90%D0%B4%D0%B5%D0%BD%D0%BE%D0%B2%D0%B8%D1%80%D1%83%D1%81_%D0%BE%D0%BE%D1%80%D1%83%D0%BB%D0%B0%D1%80%D1%8BInfec%C3%A7%C3%A3o_por_adenov%C3%ADrusAdenoviroze%D0%90%D0%B4%D0%B5%D0%BD%D0%BE%D0%B2%D0%B8%D1%80%D1%83%D1%81%D0%BD%D0%B0%D1%8F_%D0%B8%D0%BD%D1%84%D0%B5%D0%BA%D1%86%D0%B8%D1%8F%D0%90%D0%B4%D0%B5%D0%BD%D0%BE%D0%B2%D1%96%D1%80%D1%83%D1%81%D0%BD%D0%B0_%D1%96%D0%BD%D1%84%D0%B5%D0%BA%D1%86%D1%96%D1%8FNhi%E1%BB%85m_tr%C3%B9ng_AdenovirusQ837054%E8%85%BA%E7%97%85%E6%AF%92%E6%84%9F%E6%9F%93
about
Human Adenovirus 36 Infection Increased the Risk of Obesity: A Meta-Analysis UpdateAdenovirus 36 and Obesity: An OverviewMolecular epidemiology of adenovirus type 7 in the United States, 1966-2000Chromatin structure of adenovirus DNA throughout infectionPre-existing immunity against Ad vectors: humoral, cellular, and innate response, what's important?.Characterization of an N-Terminal Non-Core Domain of RAG1 Gene Disrupted Syrian Hamster Model Generated by CRISPR Cas9.Hacking the Cell: Network Intrusion and Exploitation by Adenovirus E1A.A Study to Assess the Immunogenicity, Tolerability and Safety of a Malaria Vaccine and Also Its Protective Efficacy in a Malaria Challenge ModelThe Natural History of Severe Viral Infections and Characterization of Immune Defects in Patients Without Known ImmunocompromiseViral Infections in Healthy and Immunocompromised HostsCollection and Testing of Respiratory SamplesMost Closely HLA Matched Allogeneic Virus Specific Cytotoxic T-Lymphocytes (CTL)Cidofovir Instillation in Hematopoietic Stem Cell Transplant (HSCT) Recipients With Hemorrhagic CystitisEvaluate Efficacy, Immunological Response of Intratumoral/Intralesional Oncolytic Virus (OBP-301) in Metastatic MelanomaChemoradiation With Enadenotucirev as a Radiosensitiser in Locally Advanced Rectal CancerSafety and Immunogenicity of Ad4-HIV Envelope Vaccine Vectors in Healthy VolunteersAdenovirus-specific Cytotoxic T-lymphocytes for Refractory Adenovirus InfectionAd Sensor-based Real-time Diagnosis of AdenovirusAllogeneic Virus-Specific Cytotoxic T-Lymphocytes(CTL), Persistent/Recurrent Viral Infection Post-HSCT (EAP CHALLAH)Aminopeptidase N expression in the endometrium could affect endometrial receptivityManagement of adenovirus infection in patients after haematopoietic stem cell transplantation: State-of-the-art and real-life current approach: A position statement on behalf of the Infectious Diseases Working Party of the European Society of Blood aSafety Study of Adenovirus Hepatocyte Growth Factor to Treat Ischemic Heart DiseaseStudy of a Novel Therapeutic Vaccine Against Hepatitis C Using Ad6NSmut and MVA-NSmut in Chronically Infected PatientsA Placebo Controlled Comparison of Topical Zirgan Versus Genteal Gel for the Treatment of Adenovirus ConjunctivitisEfficacy and Safety of NVC-422 in the Treatment of Adenoviral ConjunctivitisPharmacokinetics of Understudied Drugs Administered to Children Per Standard of CareUsing Multi-virus Cytotoxic T-cells Following T-Cell Depleted Allogeneic HPCT for Prophylaxis Against Epstein Barr Virus, Adenovirus, And CytomegalovirusSafety, Toxicity and MTD of One Intravenous IV Injection of Donor CTLs Specific for CMV and AdenovirusSafety and Immune Response to Preventive HIV Immunization With Adenovirus Serotype 5 or 35 VectorStudy of the Safety and Immunogenicity of an Adenovirus-based Tuberculosis VaccineAC6 Gene Transfer for CHFA Phase I Gene Therapy Study of FP253/Fludarabine for Prostate CancerAdministration of Virus-Specific Cytotoxic T-LymphocytesLatent Viral Infection of Lymphoid Cells in Idiopathic Nephrotic SyndromeNon Randomized Comparative Study With ControlPhase 1 Trial of Interleukin 12 Gene Therapy for Locally Recurrent Prostate CancerPhase 1 Clinical Trial of the Safety and Immunogenicity of an Adenovirus-based TB Vaccine Administered by AerosolMost Closely Human Leukocyte Antigen (HLA)-Matched Adenovirus-specific T Lymphocytes (Viralym-A)Phase I Endovenous Administration of Oncolytic Adenovirus ICOVIR-5 in Patients With Advanced or Metastatic MelanomaSafety of and Immune Response to a DNA HIV Vaccine Followed By Boosting With One of Two Serotypes of Adenoviral Vector HIV Vaccine in Healthy Adults
P921
Q10379868-0B00466E-C027-417C-9697-9280DFA17583Q18554607-7214156e-459a-fe97-0072-634733dbadcfQ18928368-fc691bc3-405c-2053-80d4-fb78dfc70e36Q18928385-b9be7f89-4468-ad3b-783c-b805d7929e35Q18967054-692caedc-4afb-df39-fffb-08da97599c35Q18967918-3ce004a2-43b9-1c09-501a-6e5d94df6f03Q18967938-2789db0b-4667-6759-97c7-77e9f6d7af26Q769741-cfd7a0bd-4c1f-67ba-8910-6c117614793d
P279
Q26771963-8CF6ECB9-1FB4-4484-BA10-6E8DB200D18AQ26799943-75E46314-6841-40FB-A83A-DC1A3DADC748Q34583745-7CBE5FC1-DE4F-4B65-B139-38E63941126DQ37960759-2B228F86-90DC-491B-8DF1-8C6E06649CD2Q38284700-BDA5C4FF-5219-4712-B94C-29ACA753B866Q54219127-65FAABB9-489E-4A32-99A7-64AB26536B6DQ55260854-CA8B0D82-4F03-40BB-8AE0-484FAD06E06CQ63807653-6B1BDF6E-C599-4F09-BDD2-3EEE6C6B2380Q63808057-0F72BB11-2FBA-4B3C-8C59-3A95959B8991Q63813825-4861A20B-CC39-425C-9FB6-3F62874D245BQ63814004-BF2154E1-B1E8-440D-9BAC-8F9A8DA14D9EQ64040734-E4152458-35C7-477C-88BF-A8CF5B8237DEQ64139674-D297669D-89DE-460C-BE59-6592E20B35F4Q64172029-8B7CA967-94FE-49FA-8078-11C522999ACBQ64183511-38AD1419-D651-47C0-B767-4281C7C5CE34Q64186225-08DEB176-65A6-48BB-8422-6D24E2EA2CFFQ64187929-42CA5C72-54E4-4770-B88B-8A3A3269883CQ64351282-377358E1-B2A9-4526-9AE8-AA5FE4848CCBQ64354485-F2273431-35D8-4E7A-9421-83283B746B83Q64374675-7CD6E7B2-B700-40DB-85B3-EB2367B59B42Q64377075-06A761BC-7191-4AEC-B6D0-759EB38447F5Q64621651-7E64260B-8BC6-473E-A0EF-696C0DCBA630Q64640447-7C97F65E-6A45-4019-BB23-0D655091CDDBQ64646669-3D440455-3948-4CEC-A2AC-95AF95C1EB31Q64646841-EC2F9EA3-1AAE-4709-92F7-F7910B37F6F9Q64648287-CC3856F2-D58B-4A9E-BADA-9CE707C968B8Q64672414-9681C255-8130-4059-BA5C-FDE73342605EQ64679798-E1DA3EBF-27E1-4424-9D0C-F5FF477AA458Q64708991-F37E5A4D-F9E3-4B7D-BDA4-6B44320838DBQ64709076-733D5ED0-1F27-4DEB-A7D0-6404AAF5C7F2Q64710217-C5D27987-21D5-492D-990F-6070B8F0A5EAQ64722201-16238E2F-AD0E-48CA-A6C9-94559495E168Q64725433-12F3E164-9441-46FB-998D-FCB614D4F4A4Q64727253-DDF6D3C4-47F6-4302-A260-32072DCB10A7Q64816874-667DCFA1-1CB7-4A60-B752-7EA906FD0135Q65330651-A19F7148-4205-4116-ABDE-467275B41A59Q65349989-15D6B462-7C72-4CF8-BA49-FC7D0527C2AEQ65351571-27E08F5F-D860-452A-81FC-D3BD947B39A0Q65365471-5F67D441-7CDD-4F11-8E3F-142F622C1FABQ65383310-4AE578B2-E2DF-4022-87CC-177DBC1BBD52
P921
description
Adenovirus 14 u ocima
@sh
Gattung von Viren
@de
homa malsano kaŭzata de adenoviruso
@eo
human disease
@en
malattia
@it
людська інфекційна хвороба з групи ГРВІ
@uk
مرض يصيب الإنسان
@ar
name
Adenoviirusinfektsioon
@et
Adenoviroze
@ro
Infecção por adenovírus
@pt
Nhiễm trùng Adenovirus
@vi
adenovirosis
@es
adenovirus infection
@en
adenovirusinfeksjon
@nn
adenovirusozo
@eo
adénovirose
@fr
humane Adenoviren
@de
type
label
Adenoviirusinfektsioon
@et
Adenoviroze
@ro
Infecção por adenovírus
@pt
Nhiễm trùng Adenovirus
@vi
adenovirosis
@es
adenovirus infection
@en
adenovirusinfeksjon
@nn
adenovirusozo
@eo
adénovirose
@fr
humane Adenoviren
@de
altLabel
Adenoviridae infectious disease
@en
Adenoviroze
@en
adenovirus infectious disease
@en
infección por adenovirus
@es
infection à adénovirus
@fr
Аденовирусные болезни
@ru
аденовірусна хвороба
@uk
عدوى بالفيروسة الغدية
@ar
prefLabel
Adenoviirusinfektsioon
@et
Adenoviroze
@ro
Infecção por adenovírus
@pt
Nhiễm trùng Adenovirus
@vi
adenovirosis
@es
adenovirus infection
@en
adenovirusinfeksjon
@nn
adenovirusozo
@eo
adénovirose
@fr
humane Adenoviren
@de
P244
P486
P6366
P672
P1417
science/adenovirus-infection
P1814
いんとうけつまくねつ
P1995
P244
sh85000853
P2888
P2924
P31
P486
P5082
adenovirusinfeksjon
P6366
2781036101
2910970641
P672
C02.256.076.045
P699
DOID:0050298